Table 2.

Baseline Characteristics of Mothers and Children in the 2 Groups

CharacteristicAzithromycin Group
(n = 226)
Placebo Group
(n = 235)
P Value
Maternal age at delivery, mean (SD)26.5 (5.3)a26.6 (5.0).684
Mode of delivery
 Vaginal220 (97.4)233 (99.2).165
 Cesarean6 (2.7)2 (0.9)
Information at birth
 Multiple pregnancy2 (0.9)10 (4.3).037
 Sexb
  Female117 (51.8)104 (44.3).266
  Male107 (47.4)124 (52.8)
Ethnicityc
 Mandinka93 (41.2)106 (45.1).490
 Jola44 (19.5)36 (15.3)
 Wollof26 (11.5)23 (9.8)
 Fula37 (16.4)38 (16.2)
 Others24 (10.6)31 (13.2)
Season
 Dry178 (78.8)188 (80.0).909
 Wet48 (21.2)47 (20.0)
Child age at follow-up visit, mean (SD)12.24 (0.6)12.27 (0.6).486
CharacteristicAzithromycin Group
(n = 226)
Placebo Group
(n = 235)
P Value
Maternal age at delivery, mean (SD)26.5 (5.3)a26.6 (5.0).684
Mode of delivery
 Vaginal220 (97.4)233 (99.2).165
 Cesarean6 (2.7)2 (0.9)
Information at birth
 Multiple pregnancy2 (0.9)10 (4.3).037
 Sexb
  Female117 (51.8)104 (44.3).266
  Male107 (47.4)124 (52.8)
Ethnicityc
 Mandinka93 (41.2)106 (45.1).490
 Jola44 (19.5)36 (15.3)
 Wollof26 (11.5)23 (9.8)
 Fula37 (16.4)38 (16.2)
 Others24 (10.6)31 (13.2)
Season
 Dry178 (78.8)188 (80.0).909
 Wet48 (21.2)47 (20.0)
Child age at follow-up visit, mean (SD)12.24 (0.6)12.27 (0.6).486

Data are presented as No. (%) unless otherwise indicated.

Abbreviation: SD, standard deviation.

aThree missing data in the azithromycin arm.

bNine missing data (2 in the azithromycin arm and 7 in the placebo arm).

cThree missing data (2 in the azithromycin arm and 1 in the placebo arm).

Table 2.

Baseline Characteristics of Mothers and Children in the 2 Groups

CharacteristicAzithromycin Group
(n = 226)
Placebo Group
(n = 235)
P Value
Maternal age at delivery, mean (SD)26.5 (5.3)a26.6 (5.0).684
Mode of delivery
 Vaginal220 (97.4)233 (99.2).165
 Cesarean6 (2.7)2 (0.9)
Information at birth
 Multiple pregnancy2 (0.9)10 (4.3).037
 Sexb
  Female117 (51.8)104 (44.3).266
  Male107 (47.4)124 (52.8)
Ethnicityc
 Mandinka93 (41.2)106 (45.1).490
 Jola44 (19.5)36 (15.3)
 Wollof26 (11.5)23 (9.8)
 Fula37 (16.4)38 (16.2)
 Others24 (10.6)31 (13.2)
Season
 Dry178 (78.8)188 (80.0).909
 Wet48 (21.2)47 (20.0)
Child age at follow-up visit, mean (SD)12.24 (0.6)12.27 (0.6).486
CharacteristicAzithromycin Group
(n = 226)
Placebo Group
(n = 235)
P Value
Maternal age at delivery, mean (SD)26.5 (5.3)a26.6 (5.0).684
Mode of delivery
 Vaginal220 (97.4)233 (99.2).165
 Cesarean6 (2.7)2 (0.9)
Information at birth
 Multiple pregnancy2 (0.9)10 (4.3).037
 Sexb
  Female117 (51.8)104 (44.3).266
  Male107 (47.4)124 (52.8)
Ethnicityc
 Mandinka93 (41.2)106 (45.1).490
 Jola44 (19.5)36 (15.3)
 Wollof26 (11.5)23 (9.8)
 Fula37 (16.4)38 (16.2)
 Others24 (10.6)31 (13.2)
Season
 Dry178 (78.8)188 (80.0).909
 Wet48 (21.2)47 (20.0)
Child age at follow-up visit, mean (SD)12.24 (0.6)12.27 (0.6).486

Data are presented as No. (%) unless otherwise indicated.

Abbreviation: SD, standard deviation.

aThree missing data in the azithromycin arm.

bNine missing data (2 in the azithromycin arm and 7 in the placebo arm).

cThree missing data (2 in the azithromycin arm and 1 in the placebo arm).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close